‘Reusing more expensive medicines yields significant savings’ | Financial

Premium

The best of De Telegraaf

Sector investigation ABN Amro:

Amsterdam – Reuse of expensive returned medicines yields €460 million per year, according to an analysis by ABN Amro. The bank is based on a fundraising campaign by Logistics Community Brabant (LCB) in which about thirty pharmacies participated last year.

ttn-2

Bir yanıt yazın